NYSE:KVUE - New York Stock Exchange, Inc. - US49177J1025 - Common Stock - Currency: USD
24.44
+0.38 (+1.58%)
The current stock price of KVUE is 24.44 USD. In the past month the price increased by 11.75%. In the past year, price increased by 18.99%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UL | UNILEVER PLC-SPONSORED ADR | 23.76 | 153.51B | ||
EL | ESTEE LAUDER COMPANIES-CL A | 29.75 | 21.94B | ||
BRBR | BELLRING BRANDS INC | 28.13 | 7.79B | ||
COTY | COTY INC-CL A | 19.54 | 4.09B | ||
ODD | ODDITY TECH LTD-CL A | 34.98 | 3.96B | ||
IPAR | INTERPARFUMS INC | 22.57 | 3.82B | ||
ELF | ELF BEAUTY INC | 21.29 | 3.77B | ||
EPC | EDGEWELL PERSONAL CARE CO | 9.39 | 1.32B | ||
OLPX | OLAPLEX HOLDINGS INC | 15.88 | 845.52M | ||
HLF | HERBALIFE LTD | 3.27 | 682.02M | ||
USNA | USANA HEALTH SCIENCES INC | 11.94 | 556.37M | ||
HNST | HONEST CO INC/THE | N/A | 533.51M |
Kenvue, Inc. is a consumer health company. The company is headquartered in Summit, New Jersey and currently employs 22,000 full-time employees. The company went IPO on 2023-05-04. The firm operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The firm has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
KENVUE INC
1 Kenvue Way
Summit NEW JERSEY US
Employees: 22000
Phone: 19088741200
The current stock price of KVUE is 24.44 USD. The price increased by 1.58% in the last trading session.
The exchange symbol of KENVUE INC is KVUE and it is listed on the New York Stock Exchange, Inc. exchange.
KVUE stock is listed on the New York Stock Exchange, Inc. exchange.
25 analysts have analysed KVUE and the average price target is 24.76 USD. This implies a price increase of 1.29% is expected in the next year compared to the current price of 24.44. Check the KENVUE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
KENVUE INC (KVUE) has a market capitalization of 46.89B USD. This makes KVUE a Large Cap stock.
KENVUE INC (KVUE) currently has 22000 employees.
KENVUE INC (KVUE) has a support level at 24.26 and a resistance level at 24.45. Check the full technical report for a detailed analysis of KVUE support and resistance levels.
The Revenue of KENVUE INC (KVUE) is expected to decline by -0.74% in the next year. Check the estimates tab for more information on the KVUE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
KENVUE INC (KVUE) has a dividend yield of 3.41%. The yearly dividend amount is currently 0.81. Check the full fundamental report for a detailed analysis of KVUE dividend history, reliability and sustainability.
KENVUE INC (KVUE) will report earnings on 2025-08-04, before the market open.
The PE ratio for KENVUE INC (KVUE) is 22.22. This is based on the reported non-GAAP earnings per share of 1.1 and the current share price of 24.44 USD. Check the full fundamental report for a full analysis of the valuation metrics for KVUE.
The outstanding short interest for KENVUE INC (KVUE) is 1.73% of its float. Check the ownership tab for more information on the KVUE short interest.
ChartMill assigns a technical rating of 8 / 10 to KVUE. When comparing the yearly performance of all stocks, KVUE is one of the better performing stocks in the market, outperforming 90.8% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to KVUE. While KVUE is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months KVUE reported a non-GAAP Earnings per Share(EPS) of 1.1. The EPS decreased by -9.84% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 6.66% | ||
ROA | 4.02% | ||
ROE | 10.65% | ||
Debt/Equity | 0.81 |
ChartMill assigns a Buy % Consensus number of 71% to KVUE. The Buy consensus is the average rating of analysts ratings from 25 analysts.
For the next year, analysts expect an EPS growth of 2.58% and a revenue growth -0.74% for KVUE